Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform
Do you want to help us redefine how AI powers the future of Business Management software, not as an add-on, but as a core part of how people work, decide and grow ? This position is